Peel Therapeutics: Closes $9M Financing Round

Peel Therapeutics Closes $9M Financing Round

• Peel Therapeutics, a Salt Lake City, UT-based clinical-stage biotech company, secured $9M in funding, bringing its total seed financing to $36M
• The company intends to use the funds to advance clinical and pre-clinical programs
• PeelTherapeutics is a clinical-stage biotech company that is advancing a therapeutic pipeline to treat a spectrum of devastating conditions, with a near-term focus on cancer and inflammation
• The company has raised a total of $36M in seed financing, plus over $3M in non-dilutive capital
• Peel also expanded its Board of Directors to support and guide the company through this rapid growth stage
• The new additions include Ryan Watts, CEO, Denali Therapeutics and Carin Canale-Theakston, CEO, Evoke Canale